Health care resources and costs associated with delivering gene therapy for hemophilia in clinical practice. Journal Abstract - Guideline Central

Health care resources and costs associated with delivering gene therapy for hemophilia in clinical practice.

Published: 2026 Jan

Authors

, , , , , , , , ,

Abstract

The debate around the cost-effectiveness of gene therapy for hemophilia has largely centered on its price (€1-€3.5 million per individual). While previous studies have explored care organization for gene therapy delivery, none have evaluated the potential resource utilization and associated costs in a real-world setting.

Keywords: cost, gene therapy, health care resource, hemophilia, microcosting

Source

Research and practice in thrombosis and haemostasis

Publication Type

Journal Article

Language

English

PubMed ID

41541608

You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.